December 1, 2007


Keep Up with Drug Approvals, Recalls, Adverse Events


As a new service for its members, IDSA now offers via email the latest information from the Food and Drug Administration on label changes, adverse events and other safety information, newly approved drugs, and other nformation on FDA-approved drugs and biologics applicable to the field of infectious diseases.  Recent alerts have included:

To sign up for this service, IDSA members can visit http://www.idsociety.org/Content.aspx?id=4250.

< Previous Article |

Acute Infection Tool Now Available
Apply for NIH Director’s Pioneer and New Innovator Awards
HIVMA Accepting Applications for the Minority Clinical Fellowship
HIVMA Offers Fact Sheet on HIV/TB Coinfection
Include Your Practice in the HIV Provider Listing
EIN: Antibiotic Locks Common, But No Common Protocol
Stay Connected - Update your IDSA Member Profile
IDSA Advocacy Update
IDSA Members Testify at Pennsylvania Hearing on Lyme Disease
In Memoriam: Merle A. Sande, MD, FIDSA (1939-2007)
Members on the Move
Welcome, New IDSA Members!
In the IDSA Journals
Keep Up with Drug Approvals, Recalls, Adverse Events
Search Back Issues
Forward this Issue
Print-Friendly Version

© Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA